Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets Pts
Clinical trial NCT01701674 · COMPLETED
Trial details
- NCT number
- NCT01701674
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-09
- Primary completion
- 2016-04-21
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.